MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

Corporate Breaking News

Home : MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

Mar 09 2021	MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study
This approval is a key step forward in the development of the company's iSTRYM digital therapeutics platform VANCOUVER, BC, March 9, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") a leader in advanced proprietary technology...


Source:https://www.prnewswire.com:443/news-releases/mindcure-receives-unconditional-ethics-approval-for-its-psychedelic-integration-protocol-research-study-301242880.html

Related News
» Fertilizer Catalyst Market Size Worth $3.3 Billion By 2027 \| CAGR: 2.4% » iQIYI Ushers in Next-Generation of Entertainment with Launch of China's First Extended Reality (XR) Cloud Show